Home
Up
Laboratory Contact
Sample Requirements
Reporting Targets
Feedback
Site Search
Search for Tests
Downloads
Find Us
Links

 

DRPLA      

 

Last update: 14/06/2006

Background to disease

OMIM 125370

 Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disease characterised by myoclonic epilepsy, cerebellar ataxia, choreoathetosis, and dementia. Degeneration occurs in the dentatorubral and pallidoluysian parts of the central nervous system. There is clinical overlap with Huntington disease. DRPLA is extremely rare in Europeans.

 The disease is caused by an expansion of a polymorphic CAG repeat within the coding region of the ATN1 gene. Pathogenic alleles have 49 or more repeats.

 

Laboratory Analysis

Contact scientist: Lampros Mavrogiannis

 

Test Level

Test

*Target reporting time

1

CAG repeat sizing PCR

8 weeks

* Predictive testing = 14 days to report

 

 

User Guide Editor: Dr Ruth Charlton PhD DipRCPath. Copyright © 2007 . Yorkshire Regional DNA Laboratory. All rights reserved.